EN
HI
Summary
As of 11 Sep, 2026, Phaarmasia stock price is ₹88. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Phaarmasia has traded between ₹30.01 and ₹131.75.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹88.00.
Phaarmasia has an upper circuit limit of ₹92.40 and a lower circuit limit of ₹83.60. The total value traded stands at ₹0.00, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Phaarmasia also offers a dividend yield of 0%.
Phaarmasia Share Price Chart
Phaarmasia Share Key Metrics
Volume
0.00
Market Cap
60.08 CR
LTQ@LTP
0@88.00
ATP
0
Var Margin
30.02 %
Circuit Range
83.6-92.4
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
1
Phaarmasia Resistance and Support
Pivot 88
Resistance
First Resistance
88
Second Resistance
88
Third Resistance
88
Support
First Support
88
Second Support
88
Third Support
88
Phaarmasia Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 10 2026 | 88 | 88 | 0.00% | 88 | 88 |
| Wed Sep 09 2026 | 91.69 | 88 | 0.47% | 91.69 | 85.15 |
| Tue Sep 08 2026 | 85 | 87.59 | 1.04% | 89.94 | 85 |
Phaarmasia Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results & A.G.M. |
| 2026-05-29 | Audited Results |
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Phaarmasia News
Phaarmasia Ltd - 523620 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August 2026 At 05.00 PM (IST)
Phaarmasia's board approved the un-audited financial results for Q1 FY27. The board also resolved to convene the 45th Annual General Meeting and approved its draft notice, along with the Draft Directors' Report for FY26.
Aug 13 2026 17:51:25
Phaarmasia Management
| Name | Position |
|---|---|
| Urvashi Bhatia | Company Secretary & Compliance Officer |
| Naga Bhaskara Rao Yallapragada | Whole Time Director |
Phaarmasia Similar Stocks
Family Care Hospitals Ltd.
2.02
0.02 (1.00%)
Bandaram Pharma Packtech Ltd.
21.50
0.00 (0.00%)
Global Longlife Hospital and Research Ltd.
14.05
-0.03 (0.21%)
Sandu Pharmaceuticals Ltd.
37.86
0.00 (0.00%)
Cian Healthcare Ltd.
14.75
0.00 (0.00%)
Adeshwar Meditex Ltd.
15.00
0.00 (0.00%)
KK Shah Hospitals Ltd.
43.00
0.00 (0.00%)
GKB Ophthalmics Ltd.
65.00
0.41 (0.63%)
Zenith Health Care Ltd.
3.27
0.01 (0.31%)
Phaarmasia FAQs
The Buying Price of Phaarmasia share is 88 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Phaarmasia stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Phaarmasia, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Phaarmasia shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Phaarmasia shares is 0. Useful to assess the stock's value relative to its book value.
To assess Phaarmasia’s valuation compare Sector P/E, P/B which are 41.75 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Phaarmasia is 60.08 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Phaarmasia share price is 131.75 & 30.01. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Phaarmasia belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PHRMASI
